BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5364317)

  • 1. Preliminary report of beneficial effect of phenformin in combination with ethyloestrenol in treatment of cutaneous vasculitis and Behçet's syndrome.
    Menon IS; Cunliffe WJ; Dewar HA
    Postgrad Med J; 1969 May; 45():62-6. PubMed ID: 5364317
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of phenformin and ethyloestrenol or stanozolol in the treatment of decreased fibrinolytic states. (Cutaneous vasculitis, Raynaud's disease, Behcet's syndrome, recurrent deep vein thrombosis and post myocardial infarction).
    Menon IS
    Acta Univ Carol Med Monogr; 1972; 52():19-23. PubMed ID: 4669824
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of Behcet's syndrome with phenformin and ethyloestrenol.
    Cunliffe WJ; Menon IS
    Lancet; 1969 Jun; 1(7608):1239-40. PubMed ID: 4182415
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolysis in cutaneous vasculitis.
    Cunliffe WJ
    Proc R Soc Med; 1971 Sep; 64(9):928. PubMed ID: 5114293
    [No Abstract]   [Full Text] [Related]  

  • 5. Mode of action of phenformin plus ethyloestrenol on fibrinolysis.
    Fearnley GR; Chakrabarti R; Evans JF
    Lancet; 1971 Apr; 1(7702):723-5. PubMed ID: 4101428
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and laboratory double-blind investigation on effect of fibrinolytic therapy in patients with cutaneous vasculitis.
    Dodman B; Cunliffe WJ; Roberts BE; Sibbald R
    Br Med J; 1973 Apr; 2(5858):82-4. PubMed ID: 4573315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behçet's syndrome and oral fibrinolytic therapy.
    Cunliffe WJ; Roberts BE; Dodman B
    Br Med J; 1973 May; 2(5864):486-7. PubMed ID: 4712497
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of colchicine and fibrinolytic therapy in Behçet's disease.
    Graham-Brown RA; Sarkany I
    Clin Exp Dermatol; 1980 Mar; 5(1):87-92. PubMed ID: 7398131
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenformin and stanozolol in blood fibrinolytic activity.
    Menon IS; Cunliffe WJ; Weightman D; Dewar HA
    Br Med J; 1970 Feb; 1(5693):428. PubMed ID: 4244848
    [No Abstract]   [Full Text] [Related]  

  • 10. Experiences in the use of fibrinolytic agents in Behcet's syndrome.
    Kirk J; Handley DA
    Australas J Dermatol; 1972 Apr; 13(1):5-10. PubMed ID: 5082495
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolytic therapy for vasculitis of atrophie blanche.
    Gilliam JN; Herndon JH; Prystowsky SD
    Arch Dermatol; 1974 May; 109(5):664-7. PubMed ID: 4828532
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenformin and ethyloestrenol in recurrent deep venous thrombosis (DVT).
    Hedner U; Nilsson IM; Isacson S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):372-80. PubMed ID: 63424
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenformin plus ethyloestrenol in survivors of myocardial infarction. Three-year pilot study.
    Chakrabarti R; Fearnley GR
    Lancet; 1972 Sep; 2(7777):556-9. PubMed ID: 4115736
    [No Abstract]   [Full Text] [Related]  

  • 14. The value of phenformin and ethyloestrenol in the prevention of deep venous thrombosis in patients undergoing surgery.
    Atkins P; Brown IK; Downie RJ; Haggart BG; Littler J; Robb PM; Santer GJ; Jones I
    Thromb Haemost; 1978 Feb; 39(1):89-96. PubMed ID: 580509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenformin and ethyloestrenol for Raynaud's disease.
    Fearnley GR; Chakrabarti R
    Lancet; 1969 Nov; 2(7631):1203. PubMed ID: 4187238
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenformin and ethyloestrenol for Raynaud's disease.
    Fearnley GR; Chakrabarti R
    Lancet; 1969 Oct; 2(7626):906-7. PubMed ID: 4186475
    [No Abstract]   [Full Text] [Related]  

  • 17. Behcet's syndrome: clinical, immunological and therapeutic evaluation of 17 patients.
    Cooper DA; Penny R
    Aust N Z J Med; 1974 Dec; 4(6):585-96. PubMed ID: 4533949
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.
    Fearnley GR; Chakrabarti R; Hocking ED
    Lancet; 1967 Nov; 2(7524):1008-11. PubMed ID: 4168522
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenformin and ethyloestrenol in scleroderma.
    Paolino JS; Kaplan D; Lazarus R; Emmanuel G; Diamond HS
    Lancet; 1972 May; 1(7758):1023. PubMed ID: 4112353
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.
    Nilsson IM; Isacson S
    J Clin Pathol; 1972 Jul; 25(7):638-9. PubMed ID: 5070268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.